Massachusetts Financial Services
MIRM icon

Massachusetts Financial Services’s Mirum Pharmaceuticals MIRM Stock Holding History

Massachusetts Financial Services’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45M Buy
384,570
+98,164
+34% +$9.86M 0.01% 517
2026
Q1 		$26.5M Buy
+286,406
New +$26.9M 0.01% 587

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services's MIRM Position: Q2 2026 in Review

Massachusetts Financial Services increased its Mirum Pharmaceuticals (MIRM) stake by 34% in Q2 2026, buying an estimated $9.86M and bringing the position to 384,570 shares worth $45M. The position accounts for 0.01% of the portfolio, ranked #517.

Massachusetts Financial Services first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Massachusetts Financial Services held 384,570 shares of Mirum Pharmaceuticals worth $45M as of Q2 2026.
  • Massachusetts Financial Services bought 98,164 Mirum Pharmaceuticals shares in Q2 2026, an estimated $9.86M.
  • Mirum Pharmaceuticals made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #517 holding.
  • Massachusetts Financial Services first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.